Month: April 2023

We get a lot of questions from readers about what you can do to help a hospitalized family member or friend. Patients love the sentiment, but most have their fill of robes, fluffy slippers and lavender scented lotions and potions. Recently, friends of OncoLink, Stephanie and Whitney, shared with me what they did for their
0 Comments
Over-the-scope clips (OTSC) may prevent further bleeding more so than standard endoscopic treatment when used as primary treatment in patients with high-risk nonvariceal upper gastrointestinal lesions, shows a randomized controlled trial (RCT). However, noted the investigators, writing in Annals of Internal Medicine, and physicians who wrote an accompanying editorial, reservations remain about first-line use of OTSCs, but mostly
0 Comments
RAHWAY, N.J.–(BUSINESS WIRE) April 3, 2023 — Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, in combination with Padcev (enfortumab vedotin-ejfv) for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (la/mUC)
0 Comments
As well as recently celebrating Cancer Research UK’s 20th birthday, this year also marks 20 years of our Flame of Hope Awards. The Flame of Hope Awards are our annual celebration of our most outstanding and dedicated supporters and volunteers. Since the first ceremony in 2003 we’ve presented almost 2000 awards to thank the amazing
0 Comments
NEW ORLEANS — More than one third of pediatric residency programs do not have a pediatric rheumatologist on faculty, a situation that has changed little since 2004, according to a poster presented at the Pediatric Rheumatology Symposium 2023 conference. “This shortage has significant downstream effects,” according to author Miriah Gillispie-Taylor, MD, an assistant professor of
0 Comments
Today’s Kidney Dialysis Options for People With Diabetes – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2023 Everyday Health, Inc., a Ziff Davis company. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not be used by
0 Comments
Thought LeadersIshani MalhotraCEOCarcinotech In this interview, we speak to Ishani Malhotra, CEO of Carcinotech, about their 3D-printed tumor replicas that are being used to better understand personalized cancer treatments.  Please can you introduce yourself and tell us about your role at Carcinotech? Ishani Malhotra, Chief Executive Officer and founder of Carcinotech, has nine years of
0 Comments
A statement released by the American Heart Association (AHA) and the American College of Cardiology (ACC) advocates use of supervised exercise training in patients with heart failure with preserved ejection fraction (HFpEF), as well as coverage for these services by third party payers. The authors hope to boost the stature of supervised exercise training (SET)
0 Comments
fruquintinib Treatment for Colorectal Cancer HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer Hong Kong, Shanghai & Florham Park, NJ — Friday March 31, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM, HKEX:​13) today announces that it completed the rolling submission of a New Drug Application
0 Comments
RAHWAY, N.J.–(BUSINESS WIRE) March 29, 2023 — Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to Keytruda, Merck’s anti-PD-1 therapy, for the treatment of adult and pediatric patients with unresectable or metastatic microsatellite instability-high (MSI-H) or
0 Comments
March 31, 2023 Audience: Health Professional, Pharmacy, Consumer March 31, 2023 – Piscataway, NJ, Camber Pharmaceuticals, Inc. is voluntarily recalling lot # E220182 of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the potential Bacillus cereus contamination in the product. Risk Statement: In the population most at risk, immunocompromised population, there is
0 Comments
Meet Kathy Molloy. She’s one of the 2023 Senior Planet Sponsored Athletes, and she’ll be sharing updates on her health and wellness journey through the rest of this year. Kathy, age 73, considered herself to be in good physical condition for most of her life. But after receiving some shocking health news in her late
0 Comments
What causes Post-Traumatic Stress Disorder? Dr. Monica Taylor-Desir, M.D., M.P.H., a community psychiatrist at Mayo Clinic, talks you through the symptoms, causes, and treatments for Post-Traumatic Stress Disorder (PTSD). Get informed: https://mayocl.in/42BLK58 From Mayo Clinic to your inbox, sign-up for free: https://mayocl.in/3e71zfi 0:00     Introduction 0:30     What is PTSD? 1:00     Exposure 1:22     Symptoms 2:41     Treatment 3:22
0 Comments
Smartwatches are designed to be more than just timepieces. Aside from tracking schedules, location and activities, they boast health-monitoring capabilities, especially activities affecting heart health. Many Americans spend hundreds to thousands of dollars on the latest wearable devices thinking the more sophisticated and advanced they are, the better their chances of saving their lives. But
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. An antiviral therapy in early development has the potential to prevent COVID-19 infections when given as a nasal spray as little as 4 hours before exposure. It also appears to work as a treatment if used within 4 hours after infection
0 Comments
CARLSBAD, Calif., March 29, 2023. Ionis Pharmaceuticals, Inc. today reported that its partner Biogen presented new Phase 1b clinical data showing that IONIS-MAPTRx (BIIB080) reduced soluble tau protein in cerebrospinal fluid (CSF) in a dose-dependent and sustained manner in patients with early-stage Alzheimer’s disease (AD). IONIS-MAPTRx also reduced aggregated tau pathology, as measured by positron
0 Comments
Researchers led by a team at UT Southwestern Medical Center have created a statistical model to identify standards for typical, high, or low rates of bleeding after pediatric tonsillectomies. The findings, published in JAMA Otolaryngology-Head & Neck Surgery, could help doctors and hospitals improve outcomes for the third-most common pediatric surgery in the U.S. This
0 Comments
Members of the media ask questions to U.S. President Joe Biden as he walks to the Marine One helicopter to depart for travel to Mississippi to view tornado damage, from the White House in Washington, U.S., March 31, 2023.  Jonathan Ernst | Reuters The Biden administration on Friday appealed a Texas federal judge’s decision to
0 Comments